CFM Holdings has entered into a sale and purchase agreement (SPA) to acquire 51 per cent of the total issued ordinary share capital of SING-SWE MM Biotechnology for an aggregate consideration of up to S$6.1 million.



READ SOURCE

READ  Withdrawals from casino junkets threaten Macau's economy

LEAVE A REPLY

Please enter your comment!
Please enter your name here